Kevin R. McCarthy
- Virology top 2%
- HIV Research and Treatment 7
- Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research 5
- Epidemiology top 5%
- Influenza Virus Research Studies 14
- Virology and Viral Diseases 14
- Herpesvirus Infections and Treatments 14
- Cytomegalovirus and herpesvirus research 10
- Respiratory viral infections research 6
- Immunology top 5%
- Immunology and Allergy top 5%
-
- Virus-based gene therapy research 12
- Co-authors
- John F. EndersMichael J. DuffyLindsey R. Robinson‐McCarthyW. Paul DuprexA. W. DownieWilliam BainSham NambulliGhady Haidar
- Partner nations
- United KingdomUnited StatesIreland
In The Last Decade
Kevin R. McCarthy
68 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 92
- Virology 295
- Infectious Diseases 720
- Epidemiology 972
- Immunology 469
- Immunology and Allergy 113
Countries citing papers authored by Kevin R. McCarthy
This map shows the geographic impact of Kevin R. McCarthy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin R. McCarthy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin R. McCarthy more than expected).
Fields of papers citing papers by Kevin R. McCarthy
This network shows the impact of papers produced by Kevin R. McCarthy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin R. McCarthy. The network helps show where Kevin R. McCarthy may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kevin R. McCarthy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 11 | |
| 4 | 2024 | 9 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 6 | |
| 7 | 2022 | 5 | |
| 8 | Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escapebreakdown → | 2021 | 332 |
| 9 | 2021 | 21 | |
| 10 | 2019 | 123 | |
| 11 | 2019 | 108 | |
| 12 | 2018 | 18 | |
| 13 | 2018 | 104 | |
| 14 | 2013 | 41 | |
| 15 | 1968 | 30 | |
| 16 | 1967 | 14 | |
| 17 | 1964 | 17 | |
| 18 | 1964 | 44 | |
| 19 | 1957 | 44 | |
| 20 | 1952 | 2 |
About Kevin R. McCarthy
Kevin R. McCarthy is a scholar working on Virology, Epidemiology and Issues, ethics and legal aspects, having authored 72 papers that have together received 2.2k indexed citations. Recurring topics across this work include Influenza Virus Research Studies (14 papers), Virology and Viral Diseases (14 papers), Herpesvirus Infections and Treatments (14 papers), Virus-based gene therapy research (12 papers), Cytomegalovirus and herpesvirus research (10 papers), HIV Research and Treatment (7 papers), Respiratory viral infections research (6 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). The work is most often cited by research in Virology (295 citations), Infectious Diseases (720 citations) and Epidemiology (972 citations). Kevin R. McCarthy has collaborated with scholars based in United Kingdom, United States and Ireland. Frequent co-authors include John F. Enders, Michael J. Duffy, Lindsey R. Robinson‐McCarthy, W. Paul Duprex, A. W. Downie, William Bain, Sham Nambulli, Ghady Haidar, Linda J. Rennick and Anna Mitus. Their work appears in journals such as Science, New England Journal of Medicine and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.